Skip to main content
. 2011 Oct 20;6(10):e26342. doi: 10.1371/journal.pone.0026342

Table 2. Gene expression in FLS after stimulation with IL-17A.

mRNA copies/β2 microglobulin×100
Control IL-17A p-value
IL-1β n.d. n.d. -
IL-6 0.065±0.01 2.1±0.3 0.003
KC/CXCL1 6.4±0.6 80.4±18.1 0.015
MIP-2/CXCL2 0.14±0.03 0.33±0.09 0.102
LIX/CXCL5 27.8±1.7 641.9±123.5 0.008
MIP-1γ/CCL9 1.1±0.1 2.0±0.2 0.015
MIP-3α/CCL20 0.02±0.004 0.74±0.16 0.011
MIP-1α/CCL3 0.17±0.02 0.14±0.03 0.360
MIP-3β/CCL19 0.44±0.05 0. 80±0.13 0.059
MCP-3/CCL7 40.7±4.4 252.4±49.5 0.013
RANTES/CCL5 0. 32±0.086 0.60±0.09 0.091
RANKL 1.37±0.05 7.4±1.1 0.006
IL-33 1.9±0.14 3.15±0.48 0.068
VEGF-A 20.5±1.4 24.0±5.3 0.553
MMP2 277.3±38.4 271.6±41.4 0.924
MMP3 115.3±16.9 339.5±45.0 0.010
MMP13 103.3±3.3 249.2±71.3 0.110

Genes induced in FLS by IL-17A. FLS were left unstimulated or stimulated with 100 ng/ml IL-17A. After 16 h, total RNA was harvested and gene expression was determined by qPCR. Data shown represent the 100-fold of the mean of mRNA copies/β2 microglobulin mRNA copies ± SEM (n = 3 independent experiments). Differences were evaluated by unpaired two-tailed Student's t test; p<0.05 was considered statistically significant and is indicated in bold.